Romvimza 14 MG capsule UU 8S
Ended Awarded
- Contract number
- SPE2DR26FXU5E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,660
Award facts
- Contract value 100% obligated
- $18,660.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $18,660.36 delivery order to AmerisourceBergen Drug Corp on June 4, 2026, for ROMVIMZA 14 mg capsule supply with an ultimate completion date of June 26, 2026.
Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FXU5E?
SPE2DR26FXU5E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2026.
How much is contract SPE2DR26FXU5E worth?
The government has obligated $18,660 on SPE2DR26FXU5E.
Is contract SPE2DR26FXU5E an order under another contract?
Yes. SPE2DR26FXU5E is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXU5E competed?
The extent of competition for SPE2DR26FXU5E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award